Lotus Health Group Hits Day Low of CNY 8.93 Amid Price Pressure

Lotus Health Group Co., a large-cap player in the FMCG sector, experienced a significant decline today, with its stock price dropping by 9.98% to touch an intraday low of CNY 8.93. This performance starkly contrasts with the China Shanghai Composite, which fell by 3.05% on the same day. Over the past week, Lotus Health has seen a more pronounced downturn, with a 1-week performance decline of 18.22%. The stock's performance over the past month is even more concerning, showing a decrease of 39.09%. Despite these recent challenges, the company has demonstrated resilience over the longer term, with a 1-year performance increase of 43.11%, significantly outperforming the broader market's 7.03% gain. Key financial metrics reveal a return on equity (ROE) of 14.42% and a price-to-earnings (P/E) ratio of 53.00, indicating a relatively high valuation. The company's inventory turnover ratio stands at 13.53 times, marking a low point. While Lotus Health Group Co. has faced headwinds recently, its long-term performance remains noteworthy in the context of the FMCG industry.